Publicaciones en las que colabora con María Lourdes Vázquez López (9)

2022

  1. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients

    Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550

2014

  1. ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

    Annals of hematology, Vol. 93, Núm. 10, pp. 1745-1753

  2. Late differentiation syndrome in acute promyelocytic leukemia: A challenging diagnosis

    Hematology Reports, Vol. 6, Núm. 4, pp. 75-77

2005

  1. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning

    Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 6, pp. 437-447

2004

  1. Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation

    Bone Marrow Transplantation, Vol. 33, Núm. 2, pp. 183-187

2002

  1. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

    Leukemia, Vol. 16, Núm. 8, pp. 1423-1431

1999

  1. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

    Bone Marrow Transplantation, Vol. 24, Núm. 12, pp. 1279-1283

  2. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation

    Bone Marrow Transplantation, Vol. 23, Núm. 9, pp. 901-905

  3. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery

    Haematologica, Vol. 84, Núm. 6, pp. 511-516